169
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Vascular Health Promotion Project and Vascular Medicine in China-CCVM2004-2023

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 741-751 | Received 27 Jul 2023, Accepted 25 Oct 2023, Published online: 13 Nov 2023
 

Abstract

Cardiovascular disease(CVD) has become a major disease burden affecting people’s health in China. Blood vessels are very important for human health and are the “sentinel” for the development of many cardiovascular and cerebrovascular diseases. The key to effectively preventing fatal, disabling heart, brain and peripheral vascular events lies in controlling traditional and non-traditional risk factors for vascular health from the source, and early assessment and intervention of early vascular lesions. Since 2004, China government promoted the early detection technology of vascular lesions and vascular medicine, and proposed the Beijing Vascular Health Stratification (BVHS) to provide suggestions for the examination, evaluation and management of risk factors, and to provide new ideas for lifelong maintenance of vascular health. This review mainly introduces the establishment and development of the clinical discipline of “vascular medicine” in the past 20 years in China, introduces the indicators for detecting vascular function and structure and the predictive value of vascular events, and carries out intelligent and digital management of vascular health throughout the life cycle of individualized prevention, treatment and rehabilitation for people with different parts or degrees of lesions, effectively reducing the occurrence and development of cardiovascular and cerebrovascular diseases, and the prospect of new technology in maintaining vascular health.

Author Contributions

All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

Disclosure

The authors report no conflicts of interest in this work.

Additional information

Funding

This work was supported by the fund of National Key R&D Program of China, grant number (2017YFC0113000, 2017YFC0113003, and 2017YFC0113005); the Industry-University-Research Innovation Fund of the Science and Technology Development Center of the Ministry of Education—“Intelligent Integration and Education”, grant number (2018A02004); The value of vascular Health assessment System on Predicting Vascular Events and its Related Mechanism Exploration, Clinical Key Clinical Construction Project of Peking University Shougang Hospital, 2019 (project no.:2019-Yuan-LC-01);The relationship between Advanced Glycation End Products, vascular endothelial function and lower extremity arterial disease; 2020, Peking University Shougang Hospital Shouyi Medical Group Science and Technology Fund (project no.:SGYYQ202005); the Beijing Municipal Health Commission, 2020, Capital Health Development Research Project (independent innovation), “Prospective cohort study on the predictive value of vascular structure and function combined evaluation for cardiovascular and cerebrovascular events-The value of the application on Beijing Vascular Health Stratification (project number:2020-2-6042)”; the Beijing Municipal Health Commission, National Cardiovascular Disease and risk factors Monitoring Project-Cardiovascular disease and risk factors monitoring in Chinese residents (2021); the Project of Key medical disciplines/schools of Shijingshan district, Beijing (2021–2023); the Project of China Digital Heart and Vascular Health Study supported by Peking University Shougang Hospital Scientific Research and Development Fund (SGYYZ202105).